BCL2L1 and central nervous system cancer: Consistent with our in vitro results, we found that ABBV-155 caused a single dependency on MCL-1 in both xenograft models, supporting the conclusion that ABBV-155 can ablate the BCL-XL block in orthotopic glioma xenografts (Fig. 6).